Life-threatening toxicities upon Pembrolizumab intake: could pharmacokinetics be the bad guy?

Hamimed, M; Devillier, R; Weiller, PJ; Marin, C; Schiano, JM; Belmecheri, N; Etienne-Grimaldi, MC; Ciccolini, J; Harbi, S

Ciccolini, J (通讯作者)，Aix Marseille Univ, SMARTc Unit, CRCM Inserm U1068, Marseille, France.;Ciccolini, J (通讯作者)，Aix Marseille Univ, COMPO, CRCM Inserm U1068, Marseille, France.;Ciccolini, J (通讯作者)，Aix Marseille Univ, INRIA Sophia Antipolis, Marseille, France.;Ciccolini, J (通讯作者)，La Timone Univ Hosp Marseille, Clin Pharmacokinet Lab, Marseille, France.

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2023; ():

Abstract

PurposeWe report the case of an adult patient diagnosed with Hodgkin's lymphoma who was scheduled for Pembrolizumab after failure of standard therapy.......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索